Director Shareholding

GlaxoSmithKline PLC 07 June 2004 Director's Interests Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan, which is notionally held in GSK Ordinary Share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Directors on 7 June 2004 of a decrease in the notional allocation of Ordinary Share ADRs on 4 June 2004 at a price of $42.37 per share: - Dr J P Garnier 1 Dr T Yamada 1 S M Bicknell Company Secretary 7 June 2004 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings